Objective Mutations in the telomerase reverse transcriptase (TERT) promoter have been
reported as a convincing prognostic factor in papillary thyroid carcinomas (PTCs). We aimed …

Background: The role of telomerase reverse transcriptase (TERT) promoter mutations in
differentiated thyroid cancer has been well established. These mutations have a significantly …

Background: Transcriptional activating mutations of telomerase reverse transcriptase (TERT)
are associated with more aggressive thyroid cancer. We evaluated the significance of TERT …

Background: Papillary thyroid cancer (PTC) has the highest cancer incidence in Korea. It is
known that some thyroid cancers have aggressive clinical behavior and a poor prognosis …

Background: Telomerase reverse transcriptase (TERT) promoter mutations have been found
in a subset of papillary thyroid carcinomas (PTCs) and are associated with tumor …

Background: Telomerase reverse transcriptase promoter (TERT p) mutations are related to a
worse prognosis in various malignancies, including papillary thyroid carcinoma (PTC). Since …

Abstract Telomerase-reverse-transcriptase (TERT) promoter mutations have been recently
described in tumors. In the present large series, TERT mutations were found in 12% of …

The role of telomerase reverse transcriptase (TERT) gene promoter mutations in the
aggressiveness of papillary thyroid cancer (PTC) remains to be further investigated. Here we …

Purpose A telomerase reverse transcriptase (TERT) promoter mutation was identified in
thyroid cancer. This TERT promoter mutation is thought to be a prognostic molecular marker …

Background The prognostic value of the telomerase reverse transcriptase (TERT) promoter
mutation, resulting in poor clinical outcomes of papillary thyroid carcinoma (PTC), has been …